10
results
for author:"Ikemoto K."
in Literature Citations
| Differential involvement of striosome and matrix dopamine systems in a transgenic model of dopa-responsive dystonia. Sato K., Sumi-Ichinose C., Kaji R., Ikemoto K., Nomura T., Nagatsu I., Ichinose H., Ito M., Sako W., Nagahiro S. et al. Proc. Natl. Acad. Sci. U.S.A. 105:12551-12556(2008) · Mapped (1) |
| Augmentation of vascular remodeling by uncoupled endothelial nitric oxide synthase in a mouse model of diabetes mellitus. Sasaki N., Yamashita T., Takaya T., Shinohara M., Shiraki R., Takeda M., Emoto N., Fukatsu A., Hayashi T., Ikemoto K. et al. Arterioscler. Thromb. Vasc. Biol. 28:1068-1076(2008) · Mapped (4) |
| Genetically rescued tetrahydrobiopterin-depleted mice survive with hyperphenylalaninemia and region-specific monoaminergic abnormalities. Sumi-Ichinose C., Urano F., Shimomura A., Sato T., Ikemoto K., Shiraishi H., Senda T., Ichinose H., Nomura T. J. Neurochem. 95:703-714(2005) · Mapped (2) |
| Effects of smoking and cytochrome P450 2D6*10 allele on the plasma haloperidol concentration/dose ratio. Ohara K., Tanabu S., Yoshida K., Ishibashi K., Ikemoto K., Shibuya H. Prog. Neuropsychopharmacol. Biol. Psychiatry 27:945-949(2003) · Mapped (18) |
| The prognosis in spindle-cell sarcoma depends on the expression of cyclin-dependent kinase inhibitor p27(Kip1) and cyclin E. Goto Y., Kawauchi S., Ihara K., Ikemoto K., Ohi R., Kawai S., Sasaki K. Cancer Sci. 94:412-417(2003) · Mapped (9) |
| Effects of age and the CYP2D6*10 allele on the plasma haloperidol concentration/dose ratio. Ohara K., Tanabu S., Ishibashi K., Ikemoto K., Yoshida K., Shibuya H. Prog. Neuropsychopharmacol. Biol. Psychiatry 27:347-350(2003) · Mapped (18) |
| CYP2D6*10 alleles do not determine plasma fluvoxamine concentration/dose ratio in Japanese subjects. Ohara K., Tanabu S., Ishibashi K., Ikemoto K., Yoshida K., Shibuya H. Eur. J. Clin. Pharmacol. 58:659-661(2003) · Mapped (18) |
| Exon 3 of tyrosine hydroxylase gene: lack of association with Japanese schizophrenic patients. Ota M., Nakashima A., Ikemoto K., Nojima S., Tanaka M., Okuda M., Koga H., Mori K., Kaneko Y.S., Fujiwara K. et al. Mol. Psychiatry 6:315-319(2001) · Mapped (20) |
| Cholesterol-lowering effects of NTE-122, a novel acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor, on cholesterol diet-fed rats and rabbits. Azuma Y., Kawasaki T., Ikemoto K., Obata K., Ohno K., Sajiki N., Yamada T., Yamasaki M., Nobuhara Y. Jpn. J. Pharmacol. 78:355-364(1998) · Mapped (1) |
| A 718-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 12.7-28.0 min region on the linkage map. Oshima T., Aiba H., Baba T., Fujita K., Hayashi K., Honjo A., Ikemoto K., Inada T., Itoh T., Kajihara M. et al. DNA Res. 3:137-155(1996) · UniProtKB (599) |
